OncLive.com路 @OncLive 路 X路路 18 hours agoScore45
Body
WATCH 馃憖: Johanna Enke, MD, of @UCLAHealth discusses safety findings from a phase 2 study of lutetium Lu 177 vipivotide tetraxetan rechallenge in mCRPC at #ESMO26
See here 鉃★笍: https://www.onclive.com/view/dr-enke-on-interim-safety-data-for-lutetium-lu-177-vipivotide-tetraxetan-retreatment-in-mcrpc
#pcsm #oncology
135 views 路 2 likes 路 0 reposts 路 0 replies
Source: OncLive.com 路 x.com